Last updated 14 days ago

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

1020 patients around the world
Available in Chile, United States
The protocol consists of 2 studies. Study 1 includes induction and maintenance treatment, and Study 2 includes only induction treatment. Each study has its own hypotheses and outcome measures that will be assessed independently.
Merck Sharp & Dohme LLC
2Research sites
1020Patients around the world
This study is for people with
Ulcerative colitis
Moderate/severe ulcerative colitis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Centro de Estudios Clínicos e Investigaciones Médicas CeCim
Recruiting
Paseo Bulnes 79, oficina 27, Santiago, Región Metropolitana
Clinical Research Chile SpA
Recruiting
Beauchef 683, Valdivia, Los Ríos
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy